BARCLAYS PLC - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 10 filers reported holding INNATE PHARMA S A in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$10.0%4120.0%0.00%
Q2 2023$10.0%4120.0%0.00%
Q1 2023$1
-50.0%
4120.0%0.00%
Q4 2022$2412
+235.0%
0.00%
Q3 2022$0
-100.0%
123
-94.4%
0.00%
Q2 2022$6,000
-45.5%
2,179
-36.1%
0.00%
Q1 2022$11,0003,4110.00%
Other shareholders
INNATE PHARMA S A shareholders Q1 2023
NameSharesValueWeighting ↓
BANK OF AMERICA CORP /DE/ 46,749$133,2350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 61,899$1760.00%
MORGAN STANLEY 48,722$138,8580.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,315$37,8150.00%
Steward Partners Investment Advisory, LLC 500$1,4250.00%
Optiver Holding B.V. 224,097$636,4350.00%
BARCLAYS PLC 412$10.00%
ROYAL BANK OF CANADA 124$00.00%
UBS Group AG 1,259$3,5880.00%
View complete list of INNATE PHARMA S A shareholders